The entorhinal cortex (EC) is regarded as the gateway to the hippocampus and thus is essential for learning and memory. Whereas the EC expresses a high density of GABA B receptors, the functions of these receptors in this region remain unexplored. Here, we examined the effects of GABA B receptor activation on neuronal excitability in the EC and spatial learning. Application of baclofen, a specific GABA B receptor agonist, inhibited significantly neuronal excitability in the EC. GABA B receptor-mediated inhibition in the EC was mediated via activating TREK-2, a type of two-pore domain K + channels, and required the functions of inhibitory G proteins and protein kinase A pathway. Depression of neuronal excitability in the EC underlies GABA B receptor-mediated inhibition of spatial learning as assessed by Morris water maze. Our study indicates that GABA B receptors exert a tight control over spatial learning by modulating neuronal excitability in the EC.
INTRODUCTION
g-Aminobutyric acid (GABA) is a major inhibitory neurotransmitter in the central nervous system, where it acts at ionotropic (GABA A and GABA C ) and metabotropic (GABA B ) receptors. Whereas the functions of GABA A and GABA C receptors are to mediate fast inhibitory synaptic transmission, stimulation of GABA B receptors (GABA B Rs) modulates synaptic function via G proteins and intracellular signals (Couve et al., 2000) . GABA B Rs consist of heterodimers of GABA B1 and GABA B2 subunits that are coupled to inhibitory G proteins (Ga i and Ga o ), which inhibit adenylyl cyclase (AC), resulting in a reduction in cyclic AMP (cAMP) generation and an inhibition of protein kinase A (PKA) (Couve et al., 2000) . GABA B Rs play important modulatory roles in cognition, nociception, neuroprotection, depression, addiction, and epilepsy (Couve et al., 2000) .
Anatomically, the entorhinal cortex (EC) mediates the majority of the connections between the hippocampus and other cortical areas (Witter et al., 1989 (Witter et al., , 2000a . Sensory inputs converge onto the superficial layers (layers II-III) of the EC (Burwell, 2000) , which give rise to dense projections to the hippocampus; the axons of the stellate neurons in layer II of the EC form the perforant path that innervates the dentate gyrus and CA3 (Steward and Scoville, 1976) , whereas those of the pyramidal neurons in layer III form the temporoammonic pathway that synapses onto the distal dendrites of pyramidal neurons in CA1 and the subiculum (Steward and Scoville, 1976; Witter et al., 2000a Witter et al., , 2000b . Moreover, neurons in the deep layers of the EC (layers V-VI) relay a large portion of hippocampal output projections back to the superficial layers of the EC Amaral, 1998a, 1998b; Kohler, 1986; van Haeften et al., 2003) and to other cortical areas (Witter et al., 1989) . The EC is part of a network that aids in the consolidation and recall of memories (Haist et al., 2001; Squire et al., 2004; Steffenach et al., 2005) . Neuronal pathology and atrophy of the EC are potential contributors to Alzheimer's disease (Hyman et al., 1984; Kotzbauer et al., 2001 ) and schizophrenia (Falkai et al., 1988; Prasad et al., 2004) . Furthermore, the EC participates in the induction and maintenance of temporal lobe epilepsy (Avoli et al., 2002; Spencer and Spencer, 1994) .
GABA B Rs are densely expressed in the principal cells, especially the stellate neurons, of the EC (Mizukami et al., 2002) . However, the functions of GABA B Rs in this brain region remain unexplored. Because GABA B Rs and the EC are closely associated with cognitive function in the brain, we tested the hypothesis that GABA B Rs expressed in the EC modulate neuronal excitability and participate in learning and memory. Our results demonstrate that GABA B R activation drastically inhibited neuronal excitability in the superficial layers of the EC via activation of TREK-2, a type of two-pore domain K + (K 2P ) channels.
We also found that the functions of pertussis toxin (PTX)-sensitive G proteins, PKA and A-kinase anchoring proteins (AKAPs) are necessary for GABA B R-mediated inhibition in the EC. Microinjection of the GABA B R agonist, baclofen, and RpcAMPS, a specific PKA inhibitor, into the EC of rats prevented spatial learning whereas downregulation of TREK-2 channels using siRNA significantly reduced the effect of baclofen on spatial learning suggesting that GABA B R-mediated inhibition of neuronal excitability contributes significantly to spatial learning.
RESULTS

GABA B R Activation Inhibits Action Potential
Firing in the EC GABA B Rs are densely expressed in the EC, especially in the stellate neurons of the superficial layers (Mizukami et al., 2002) . Accordingly, we examined first the effects of GABA B R activation on the excitability of stellate neurons. The extracellular solution contained DNQX (10 mM), dl-APV (50 mM), and bicuculline (10 mM) to block synaptic transmission. Stellate neurons were differentiated by their location, morphology and electrophysiology properties (Deng et al., 2007) . Figure 1A shows the current-voltage responses from a stellate neuron in layer II of the EC. This neuron showed profound depolarizing voltage sags in response to hyperpolarizing current pulses (Deng et al., 2007) . Application of baclofen (100 mM), a specific GABA B R agonist, completely blocked action potential (AP) firing within 5-6 min of application (n = 6, p < 0.001, Figures 1B and 1C ). AP firing frequency recovered partially after wash for $25 min ( Figure 1C ). The effect of baclofen was mediated by GABA B Rs because application of CGP 55845 (2 mM), a specific GABA B R inhibitor, completely blocked baclofen-induced inhibition of AP firing (101% ± 2% of control, n = 7, p = 0.76, Figure 1D ). These results indicate that GABA B R activation drastically inhibits neuronal excitability in the EC.
GABA B R Activation Generates Hyperpolarization
Inhibition of AP firing could be attributable to GABA B R-induced membrane hyperpolarization. We therefore recorded the resting membrane potentials (RMPs) in current-clamp in the presence of TTX (0.5 mM) to block potential indirect effects from synaptic transmission. A negative current (À50 pA for 500 ms) was injected every 5 s to assess the changes of input resistance. Application of baclofen (100 mM) generated membrane hyperpolarization (control: À56.5 ± 1.3 mV, baclofen: À61.8 ± 1.4 mV, n = 7, p < 0.001, Figures 1E and 1F ) and reduced the input resistance (control: 98.3 ± 13.1 MU, baclfen: 75.0 ± 7.7 MU, n = 7, p < 0.006, Figure 1E ), suggesting that GABA B R activation increases membrane conductance. We then recorded the holding currents (HCs) in voltage-clamp at À60 mV, a potential close to the RMPs. Under these conditions, application of baclofen (100 mM) generated an outward HC. The maximal effect usually occurred (E) Baclofen generated membrane hyperpolarization and reduced input resistance. A negative current (À50 pA for 500 ms) was injected every 5 s to assess the changes of input resistance. Insets are the voltage traces taken before (a) and during (b) the application of baclofen. Note that baclofen induced membrane hyperpolarization and reduced the voltage responses induced by the negative current injections, suggesting a reduction in input resistance.
To exclude the influence of baclofen-induced membrane hyperpolarization on input resistance, a constant positive current (+70 pA indicated by the horizontal bar) was injected briefly to elevate the membrane potential to the initial level. Under these conditions, the voltage responses induced by the negative current injections (À50 pA) were still smaller compared with control, suggesting that baclofen-induced reduction in input resistance is not secondary to its effect on membrane hyperpolarization. 4-6 min after the beginning of baclofen application (90.9 ± 17.9 pA, n = 11, p < 0.001, Figure 1G ) and was used for statistical analysis thereafter. The EC 50 value for baclofen was calculated to be 1.03 mM ( Figure 1H ).
Baclofen-Induced Hyperpolarization Is G Protein-Dependent and Requires the Functions of PKA and AKAPs GABA B Rs are G protein coupled (Couve et al., 2000) . We next examined the requirement of G proteins in baclofen-induced hyperpolarization. We replaced the intracellular GTP with GDPb-S (4 mM), a G protein inactivator and recorded baclofen-induced changes in HCs at À60 mV. In the presence of GDP-b-S, baclofen did not significantly change the HCs (4.3 ± 2.7 pA, n = 12, p = 0.13, Figure 2A ), suggesting that baclofen-induced hyperpolarization is mediated by G proteins. We then identified the type of G proteins involved in baclofen-induced hyperpolarization. GABA B Rs activate the inhibitory G proteins (Ga i and Ga o , Couve et al., 2000) , and these G proteins are sensitive to PTX. We therefore pretreated slices with PTX (500 ng/ml) in the extracellular solution continuously oxygenated with 95% O 2 and 5% CO 2 for $8 hr. Bath application of baclofen (100 mM) failed to significantly increase the outward HCs in slices pretreated with PTX (2.5 ± 3.2 pA, n = 8, p = 0.47, Figure 2B ) whereas baclofen still increased the outward HCs in slices treated in the same fashion without PTX (98.8 ± 10.6 pA, n = 6, p < 0.001, Figure 2B ), suggesting that PTX-sensitive G proteins (Ga i or Ga o ) are involved in baclofen-induced hyperpolarization. GABA B R activation inhibits AC and reduces the levels of cAMP thereby inhibiting PKA (Couve et al., 2000) . We next determined the roles of this pathway in GABA B R-induced hyperpolarization. Intracellular dialysis of MDL-12,330A (2 mM), an AC inhibitor, via the recording pipettes for $30 min immediately after the formation of whole-cell configuration induced an outward HC (192.7 ± 19 .6 pA, n = 7, p < 0.001, Figure 2C ) and extensively reduced baclofen-induced increases in outward HCs (15.7 ± 6.4 pA, n = 7, p = 0.005 versus baclofen alone, Figure 2C ) suggesting that activity of AC is required. Likewise, intracellular application of Rp-cAMPS (1 mM), a specific PKA inhibitor, in the recording pipettes for $20 min induced an outward HC (215.1 ± 22.9 pA, n = 7, p < 0.001, Figure 2D ) and completely blocked baclofeninduced increases in outward HCs (3.8 ± 7.2 pA, n = 7, p = 0.62, Figure 2D ). Furthermore, intracellular application of KT5720 (1 mM), another PKA inhibitor, also induced an outward HC (152.3 ± 20.5 pA, n = 6, p < 0.001, data not shown) and significantly reduced baclofen-induced outward HCs (13.5 ± 6.1 pA, n = 6, p = 0.006 versus baclofen alone, Figure 2E) . These results together demonstrate that PKA pathway is necessary for baclofen-induced increases in outward HCs.
We further corroborated the roles of PKA pathway by applying forskolin (an AC activator) and 3-isobutyl-1-methylxanthine (IBMX, a phosphodiesterase inhibitor) to elevate intracellular cAMP level. Coapplication of forskolin (10 mM) and IBMX (1 mM) generated an inward HC per se (À72.4 ± 14.4 pA, n = 6, p < 0.001, Figure 2E ) and significantly reduced baclofen-induced outward HCs (35.2 ± 8.0 pA, n = 6, p = 0.011 versus baclofen alone, Figure 2E ). Moreover, application of the specific PKA activator, Sp-cAMPS (100 mM), induced an inward HC by itself (À30.5 ± 7.2 pA, n = 6, p < 0.001, Figure 2E ) and significantly diminished the effect of baclofen (4.1 ± 3.4 pA, n = 6, p < 0.001 versus baclofen alone, Figure 2E ). Finally, bath application of okadaic acid (OA, 0.1 mM), a protein phosphatase inhibitor that inhibits the dephosphorylation process, induced an inward HC (À31.9 ± 13.2 pA, n = 6, p < 0.001) and significantly reduced baclofeninduced outward HC (31.3 ± 6.0 pA, n = 6, p = 0.006 versus (E) Baclofen-induced increases in outward HCs were significantly reduced by coapplication of KT5720, forskolin plus IBMX, Sp-cAMPS, or okadaic acid (OA) (*p < 0.05, **p < 0.01 versus baclofen alone; ++p < 0.01 versus baseline = 0). (F) Inclusion of St-Ht31, the AKAP inhibitory peptide, in the recording pipettes significantly inhibited baclofen-induced increases in outward HCs, whereas application of St-Ht31P, the control peptide, had no effects. Data represent means ± SEM. baclofen alone, Figure 2E) . These results together demonstrate that PKA-mediated phosphorylation exerts a tonic control over neuronal excitability in the stellate neurons of the EC.
AKAPs play a crucial role in the functional expression of PKA by tethering PKA to other signaling substrates (Beene and Scott, 2007) . Whereas AKAPs are a diverse family of more than 50 scaffolding proteins, they share a structurally conserved PKAbinding domain (Hundsrucker and Klussmann, 2008) . Disruption of AKAPs by application of the PKA-anchoring inhibitory peptide has been shown to prevent a myriad of functions ascribed to PKA (Hundsrucker and Klussmann, 2008) . Intracellular perfusion of the AKAP inhibitory peptide (St-Ht31, 20 mM) dramatically inhibited baclofen-induced increases in outward HCs (16.5 ± 2.9 pA, n = 6, p = 0.004, Figure 2F ) compared with those when the control peptide (St-Ht31P, 20 mM) was applied via the recording pipettes (85.1 ± 16.9 pA, n = 7, Figure 2F ), demonstrating that the function of AKAPs is required for baclofeninduced hyperpolarization. Together, these results indicate that GABA B Rs exert powerful inhibition on neuronal excitability via PTX-sensitive G protein-mediated inhibition of AC-PKA pathway. . We then measured the reversal potential of baclofeninduced currents using a ramp protocol prior to and during the application of baclofen because if K + channels are involved, the currents generated by GABA B R activation should have a reversal potential close to the K + reversal potential. Application of baclofen (100 mM) in the presence of 3.5 mM K + induced a net current that had a reversal potential of À90.1 ± 4.7 mV (n = 9, Figure 3B), close to the theoretical K + reversal potential calculated by the Nernst equation (À92.2 mV) suggesting that baclofen produces membrane hyperpolarization by activating a background K + conductance. The net current generated by baclofen had an outward rectification property ( Figure 3B , inset). Further evidence to support the involvement of K + channels was that elevating extracellular K + concentration to 10 mM significantly reduced baclofen-induced outward HCs (21.9 ± 7.9 pA, n = 6, p = 0.02 versus baclofen alone, Figure 3C ). Together, these data indicate that GABA B R activation induces hyperpolarization by activating a background K + conductance. We then identified the properties of the involved K + channels.
GABA B R-Induced
Baclofen-induced increases in outward HCs were not significantly altered (versus baclofen alone) in the extracellular solution containing tetraethylammonium (TEA, 10 mM, n = 8, p = 0.32, Figure 3C ), 4-aminopyridine (4-AP, 2 mM, n = 6, p = 0.96, Figure 3C ), Cs + (3 mM, n = 5, p = 0.57, Figure 3C ), or tertiapin (50 nM, n = 7, p = 0.82, Figure 3C ) suggesting that baclofen-activated K + channels are insensitive to the classic K + channel blockers.
K 2P channels are involved in controlling RMPs and they are insensitive to the classic K + channel blockers. We next examined the roles of K 2P channels in baclofen-induced membrane hyperpolarization. K 2P channels can be divided into six subfamilies: TWIK, THIK, TREK, TASK, TALK, and TRESK (Bayliss et al., 2003; Lesage, 2003) , some of which are sensitive to Ba
2+
. We therefore tested the role of Ba 2+ in baclofen-induced membrane hyperpolarization. Inclusion of Ba 2+ (2 mM) in the extracellular solution per se generated an inward HC (À79.6 ± 22.9 pA, n = 7, p = 0.01, Figure 3D ) and subsequent application of baclofen (100 mM) induced a significantly smaller outward HC (8.6 ± 1.9 pA, n = 7, p = 0.002 versus baclofen alone, Figure 3D ). Together, our results , 1996) , and TRESK (Kang et al., 2004; Sano et al., 2003) are sensitive to Ba 2+ . TRESK channels are unlikely to be involved because they are expressed in the spinal cord and other organs but not in the brain (Kang et al., 2004; Sano et al., 2003) . We examined the immunoreactivity of TASK-1, TASK-3, TWIK-1, TREK-1, and TREK-2 in the EC using two sets of antibodies (ABs, Santa Cruz Biotechnology Inc.). Immunoreactivities for all these K 2P channels especially for TASK-1 and TREK-2 were detected in the EC ( Figure 4A ). Similar patterns of immunoreactivities were detected in the EC when the second set of K 2P ABs against distinct domains of the channels were used ( Figure S1A ) whereas preabsorption of the ABs with their corresponding blocking peptides blocked the detection of the immunoreactivities (Figure S1B) . We then identified the roles of these K 2P channels in baclofen-induced hyperpolarization by applying, via the recording pipettes, specific ABs against each channel type. The rationale for this experiment was that the epitopes for all these ABs are against intracellular C-or N-terminal domains of the channels (Goldstein et al., 2001 ) and intracellular application of these ABs would interfere with the function of the corresponding K 2P channels and block or at least reduce the effects of baclofen. To ensure a complete intracellular diffusion of the ABs, we waited for $60 min after formation of whole-cell recordings. Under these conditions, application of control Ig-G (sc-2028, n = 5, p = 0.42 versus baclofen alone, Figure 4B ) and ABs to TASK-1 (sc-32067, n = 5, p = 0.53, Figure 4Ba ), TASK-3 (sc-11322, n = 6, p = 0.97, Figure 4Bb ), TWIK-1 (sc-11483, n = 7, p = 0.71, Figure 4Bc ), and TREK-1 (sc-11554, n = 6, p = 0.31, Figure 4Bd ) failed to change baclofen-induced increment of outward HCs significantly (versus control Ig-G) whereas inclusion of the AB to TREK-2 (sc-11560) dramatically reduced baclofen-induced augmentation of outward HCs (10.9 ± 4.7 pA, n = 6, p < 0.001 versus control IgG, Figure 4Be ). We used the following approaches to confirm the specificities of the ABs further. First, intracellular application of the second TREK-2 AB (sc-11559) against distinct epitopes of TREK-2 channels also significantly reduced baclofen-induced increases in outward HCs (14.5 ± 4.9 pA, n = 7, p = 0.002 versus control Ig-G, Figure 4Be ). Similar results were obtained when the third TREK-2 AB (APC-055, Alomone Labs) was included in the recording pipettes (11.8 ± 2.9 pA, n = 6, p = 0.001 versus control Ig-G, Figure 4Bf ) whereas intracellular application of the TREK-2 AB preabsorbed with the corresponding blocking peptide significantly reduced the inhibitory effect of the TREK-2 AB (86.6 ± 13.9 pA, n = 6, p < 0.001 versus anti-TREK-2 alone, Figure 4Bf ), indicating that TREK-2 channels are indeed required. Second, we repeated the above electrophysiological experiments by intracellular application of the second set of the ABs to TASK-1, TASK-3, TWIK-1, and TREK-1. Similar results were obtained ( Figure S2 ), suggesting that these K 2P channels are not involved. Third, we transfected HEK293 cells with GFP and individual K 2P channels and immunostained the transfected cells with the K 2P ABs. Immunoreactivity of individual K 2P channels was detected only in HEK293 cells transfected with the corresponding channels and there were no cross reactions among those ABs ( Figure S3A ). Finally, we tested the effectiveness of intracellular application of the ABs to TASK-1, TASK-3, TREK-1, and TWIK-1 at inhibiting the functions of these channels in transfected cells. We applied via the recording pipettes the individual K 2P channel ABs to the HEK293 cells expressing the corresponding K 2P channels and recorded the changes of the HCs at À60 mV. Intracellular dialysis of these ABs inhibited the channel function by producing an inward HC whereas intracellular application of an irrelevant AB (anti-TREK-2) failed to change the HCs significantly ( Figures  S3B-S3E ). These data indicate that the ineffectiveness of intracellular application of ABs to TASK-1, TASK-3, TREK-1, and TWIK-1 to block the effect of baclofen in the stellate neurons of the EC was unlikely due to the inability of the ABs to inhibit these channels.
The function of TREK-2 channels is upregulated by intracellular acidification, heat and arachidonic acid (AA) (Huang and Yu, 2008; Kim, 2005) . We next tested the effects of these factors on GABA B R-mediated hyperpolarization in the EC. Intracellular acidification achieved by substituting 90 mM NaCl with 90 mM NaHCO 3 in the extracellular solution (Fakler et al., 1996; Maingret et al., 1999) induced an outward HC and significantly reduced baclofen-induced increases in outward HCs ( Figure S4 ). Elevation of the temperature in the recording chamber to 33 C also induced an outward HC by itself and significantly diminished baclofen-induced enhancement of outward HCs ( Figure S4 ). However, bath application of AA (10 mM) alone induced an inward HC instead ( Figure S4 ). Because AA interacts with many ion channels (Meves, 1994) including the cationic channels such as H- (Fogle et al., 2007) and TRP (Oike et al., 2006) channels and these channels are expressed in the EC (Dickson et al., 2000; von Bohlen Und Halbach et al., 2005) , one explanation for this unexpected result is that AA-induced inward HCs might be the neutralized effect of AA on TREK-2 and other channels such as the cationic channels. To test this possibility, we replaced extracellular NaCl with the same concentration of N-methyl-Dglucamine (NMDG)-Cl and omitted extracellular Ca 2+ to minimize the contribution of cationic channels to RMPs. Under these circumstances, application of AA indeed induced an outward HC per se ( Figure S4 ) and also significantly reduced baclofeninduced enhancement of outward HCs compared with the effect of baclofen in this condition without AA ( Figure S4 ). Collectively, these results further support the involvement of TREK-2 channels in GABA B R-mediated hyperpolarization.
We then cotransfected GABA B Rs with TREK-2 channels in HEK293 cells and recorded the HCs at À60 mV from the transfected cells. Application of baclofen (100 mM) generated an outward HC in cells cotransfected with GABA B Rs and TREK-2 channels (183 ± 41 pA, n = 7, p = 0.004, Figures 5A and 5B) whereas application of the same concentration of baclofen failed to significantly change the HCs in HEK293 cells transfected with either TREK-2 channels (0.6 ± 1.9 pA, n = 6, p = 0.78, Figures 5A and 5B) or GABA B Rs (À1.5 ± 1.5 pA, n = 6, p = 0.35, data not shown). The reversal potential for baclofen-induced current was À89.2 ± 2.2 mV in cells cotransfected with GABA B Rs and TREK-2 (n = 6, Figure 5C ), which was close to the calculated K + reversal potential (À96.1 mV) in our recording conditions. Application of TREK-2 AB (sc-11560, 40 mg/ml) via the recording pipettes to the HEK293 cells cotransfected with GABA B Rs and TREK-2 channels also generated an inward HC (À446.3 ± 84.8 pA, n = 6, p = 0.003, Figure 5D ) and significantly reduced baclofen-induced increases in outward HCs (27.9 ± 5.3 pA, n = 6, p = 0.005 versus baclofen alone in transfected cells, Figure 5D ) whereas intracellular application of TREK-1 AB (sc-11554, 40 mg/ml) failed to change baclofen-induced outward HCs (181.1 ± 18.4 pA, n = 6, p = 0.97 versus baclofen alone, Figure 5E ). Similar results were obtained by using other two TREK-2 ABs ( Figure 5F ) further demonstrating the requirement of TREK-2 channels. Finally, dialysis of Rp-cAMPS (1 mM) into the HEK293 cells expressing GABA B Rs and TREK-2 channels induced an outward HC (357.1 ± 74.7 pA, n = 7, p = 0.003, Figure 5F ) and significantly reduced the effect of baclofen (12.6 ± 14.3 pA, n = 7, p = 0.002 versus baclofen alone, Figure 5F ) demonstrating the involvement of PKA. Collectively, these results indicate that GABA B R activation inhibits PKA resulting in increases in the function of TREK-2 channels to generate hyperpolarization in the EC. In agreement with our results, both TREK-1 Murbartiá n et al., 2005) and TREK-2 Lesage et al., 2000) channels are inhibited by PKA-mediated phosphorylation.
TREK-2 channels are phosphorylated by PKA on serine 359 of the C terminus . Because our preceding results demonstrate that PKA is required for GABA B R-induced hyperpolarization, we tested the role of the PKA phosphorylation site on TREK-2 channels in GABA B R-mediated hyperpolarization in HEK293 cells coexpressing GABA B Rs and the mutant TREK-2 channels in which serine 359 was mutated to alanine (S359A) to nullify PKA-mediated phosphorylation of TREK-2 channels (Kang et al., 2007a) . Alanine substitution of this site did not prevent the expression and functions of TREK-2 channels in HEK293 cells (Kang et al., 2007a) . However, application of baclofen (100 mM) failed to change the HCs significantly in HEK293 cells coexpressing S359A mutant and GABA B Rs (5.4 ± 5.0 pA, n = 9, p = 0.32, Figure 5G ) and there was little change in the voltage-current relationship when baclofen was applied ( Figure 5H ). Together, these results indicate that serine 359, the PKA phosphorylation site on TREK-2 channels is necessary for GABA B R-mediated hyperpolarization.
GABA B R Activation in the EC Impairs Spatial Learning in Morris Water Maze via PKA-Dependent Activation of TREK-2 Channels We then tested the roles of GABA B R activation in spatial learning using Morris water maze. Rats receiving intra-EC infusion of normal saline (0.9% NaCl) (control, 1 ml/rat, n = 7 rats) acquired spatial learning rapidly as shown by a significant decrease in latency to find the hidden platform throughout the trials (F (11,66) = 5145.33, p < 0.001, Figure 6A ). Intra-EC infusion of baclofen (5 mg/rat in 1 ml, n = 8 rats) completely prevented the spatial learning of rats because the escape latencies were not reduced throughout the trials (F (11,77) = 1.682, p = 0.093, Figures 6A and  6B ). The effect of baclofen was mediated via activation of GABA B Rs because microinjection of the GABA B R antagonist, CGP55845 (1 mg/rat in 1 ml, n = 8 rats) completely blocked baclofen-induced impairment of spatial learning (F (1,14) = 47.89, p < 0.001 between CGP55845 + baclofen group and baclofen group, Figures 6A and 6B ). Because the function of PKA is involved in GABA B R-mediated depression of neuronal excitability in the EC, we then tested the roles of PKA in spatial learning. Intra-EC application of Rp-cAMPS (18 mg/rat in 1 ml, n = 8 rats) prevented spatial learning as the latencies were not significantly reduced throughout the trials (F (11,77) = 0.55, p = 0.862, Figures  6A and 6B ), suggesting that endogenous PKA controls spatial learning (Arnsten et al., 2005) . In the probe trials, control rats and rats treated with CGP55845 or CGP55845 followed by baclofen showed a significant bias for the target quadrant where the platform had been originally located (p < 0.01 for each group compared with the chance level 25%). However, rats in other (D) Intracellular application of the first TREK-2 AB (40 mg/ml) to the HEK293 cells coexpressing GABA B Rs and TREK-2 channels generated an inward HC per se and significantly reduced baclofen-induced increases in outward HCs. HCs at À60 mV were recorded immediately after the formation of whole-cell configuration and the actual HCs were used to plot the figure.
(E) Intracellular application of TREK-1 AB (40 mg/ml) had little effects on HCs and did not significantly change baclofen-induced increases in outward HCs. HCs at À60 mV were recorded immediately after the formation of whole-cell configuration and the actual HCs were used to plot the figure.
(F) Intracellular dialysis of the second TREK-2 AB (AB2, sc-11559, 40 mg/ml) into the HEK293 cells cotransfected with GABA B Rs and TREK-2 channels generated an inward holding current (n = 6, ++p < 0.01 versus baseline = 0) and significantly inhibited baclofen-induced increases in outward holding currents (n = 6, **p < 0.01 versus baclofen alone). Intracellular perfusion of the third TREK-2 AB (AB3, APC-055, Alomone labs, 40 mg/ml) induced an inward holding current (n = 6, ++p < 0.001 versus baseline = 0) and significantly inhibited the effect of baclofen (n = 6, **p < 0.01 versus baclofen alone). Intracellular application of Rp-cAMPS (1 mM) into the HEK293 cells cotransfected with GABA B Rs and TREK-2 channels induced an outward holding current (n = 7, ++p < 0.01 versus baseline = 0) and significantly reduced the effect of baclofen (n = 7, **p < 0.01 versus baclofen alone). groups failed to show preference for the target quadrant ( Figure 6C ). The microinjection sites were confirmed at the end of each experiment ( Figure 6D ). Together with the electrophysiological data, these results suggest that GABA B R activation depresses spatial learning via inhibition of PKA. The water maze performance is subject to the influences of other nonspatial learning factors, such as the sensory, motivational, emotional, or motor functions of the tested subjects. We took the following measures to ensure that the effects of baclofen and Rp-cAMPS were not produced by nonspatial learning factors. First, we examined the recorded swimming speed of the rats. Intra-EC applications of the drugs failed to alter the swimming speed of the rats ( Figure S5A ). Second, we tested the performance of the rats microinjected with 0.9% NaCl (control, 1 ml/rat, n = 7 rats), baclofen (5 mg/rat in 1 ml, n = 7 rats), and Rp-cAMPS (18 mg/rat in 1 ml, n = 7 rats) in a visible platform water maze in which no learning is involved (Rudy, 2008) . There were no significant differences for the latencies to find the visible platform among control, baclofen-, and Rp-cAMPS-treated rats (Figure S5B ). Third, we tested whether baclofen and Rp-cAMPS specifically impact the learning phase. Rats were randomly divided into three groups and received 2 days of the same acquisition trials in the hidden-platform water maze without microinjection. On day 3, the three groups of the rats were microinjected with normal saline (group 1, n = 7 rats), baclofen (group 2, n = 7 rats), and Rp-cAMPS (group 3, n = 7 rats), respectively. A probe trial with the platform unavailable was conducted for these three groups of rats 15 min after microinjection. Whereas each group of rats acquired spatial learning rapidly as demonstrated by significant decreases in latency to find the platform throughout the trials ( Figure S5C 1 ), there were no significant differences of escape latency among these three groups (Figure S5C 1 ). In the probe trials, all the three groups of rats showed a bias for the target quadrant and there were no significant differences in the time spent in the target quadrant among the three groups ( Figure S5C 2 ), demonstrating that baclofen and Rp-cAMPS specifically depress the learning phase of the performance.
We then tested the role of TREK-2 channels in GABA B R-mediated inhibition of spatial learning by applying siRNA of TREK-2 channels into the EC through osmotic pumps to knockdown TREK-2 channel expression. We used several approaches to confirm the effectiveness of siRNA. First, we immunostained the EC for TREK-2 channels in rats injected with TREK-2 siRNA or the scrambled siRNA (Scr-siRNA). Because the immunoreactivity of TREK-2 channels was lower usually in the region of $400-500 mm around the injection site in slices from siRNAtreated rats (Figure S6 ), the immunocytochemical quantification and electrophysiological recordings thereafter were limited to this range in slices from both siRNA-and Scr-siRNA-treated rats. We employed two indexes (the number and the mean optical density of TREK-2-positive cells) to quantify the results. The number of the TREK-2-positive cells in layer II of the EC from siRNA-treated rats (4.6 ± 0.4 cells/10 4 mm 2 , n = 6 rats) was markedly reduced compared with that from Scr-siRNAtreated rats (14.5 ± 0.5 cells/10 4 mm 2 , n = 6 rats, p < 0.001, Figures 7A and 7B ). The mean optical density of positive cells from siRNA-treated rats (0.18 ± 0.01 arbitrary units) was significantly lower than that of Scr-siRNA-treated rats (0.41 ± 0.02 arbitrary units, p < 0.001, Figure 7B ). Second, western blot showed that the level of TREK-2 proteins in the EC from rats treated with siRNA was significantly lower than that of rats treated with ScrsiRNA ( Figure 7C ). Third, siRNA treatment significantly reduced baclofen-induced outward HCs (101.9 ± 4.7 pA, n = 16 slices from 4 Scr-siRNA-treated rats versus 38.2 ± 5.3 pA, n = 13 slices from 4 siRNA-treated rats, p < 0.001, Figure 7D ). Fourth, the characteristic increases of TREK-2 channels in response to intracellular acidification, heat and AA (in the presence of NMDG and 0 Ca 2+ ) were significantly reduced in rats treated with siRNA compared with those of the rats treated with the Scr-siRNA ( Figure 7E) . Finally, the outward rectification of the voltagecurrent relationship of the cells in rats treated with siRNA was obviously reduced (Figure 7F ), suggesting a proportional loss of TREK-2 channels. However, the RMPs of the stellate neurons from siRNA-treated rats (À55.8 ± 1.2 mV, n = 16) were not significantly different from those of the Scr-siRNA-treated rats (À56.3 ± 1.5 mV, n = 13, p = 0.86, data not shown). One explanation is that the proportional contribution of TREK-2 channels to RMPs in siRNA-treated rats could be compensated by other K 2P channels as has been observed in TREK-1 (Heurteaux et al., 2004) and TASK-1 (Aller et al., 2005) knockout mice in which the RMPs of neurons were not changed.
We then tested the water maze performance of rats treated with TREK-2 siRNA and Scr-siRNA. Treatment of rats with siRNA (n = 8 rats) abolished baclofen-induced inhibition of spatial learning, as demonstrated by decreasing latencies of target acquisition (siRNA + baclofen group versus baclofen group, F (1,14) = 111.26, p < 0.001, Figures 7G and 7H) . However, ScrsiRNA treatment (n = 7 rats) failed to alter the effect of baclofen (Scr-siRNA + baclofen group versus baclofen group, F (1,13) = 0.208, p = 0.656, Figures 7G and 7H) . siRNA treatment tended to improve the learning ability of rats when compared with controls, as shown by the decreased latencies of the last 3 trials on the first day ( Figure 7G , p < 0.01, multivariate ANOVA), which is consistent with the notion that TREK-2 channels are involved in learning and memory (Huang and Yu, 2008; Pan et al., 2003) . In the probe trials, preferences for target quadrant were observed only in siRNA-treated rats injected with saline (36.9% ± 2.0%, p < 0.01, Figure 7I ) or baclofen (37.9% ± 2.6%, p < 0.01, Figure 7I ) whereas Scr-siRNA-treated rats injected with baclofen failed to show bias for the target quadrant (23.6% ± 4.8%, Figure 7 . Knockdown of TREK-2 Channels by siRNA Annuls Baclofen-Induced Impairment of Spatial Learning (A) TREK-2 channels were significantly knocked down after delivery of TREK-2 siRNAs to the EC. Left two panels: immunoreactivity of TREK-2 channels in a region of the EC adjacent to the injection site from rats treated with Scr-siRNA or siRNA in low magnification. Right two panels: high magnification of the regions denoted in the left two panels. (B) siRNA treatment significantly deceased the number of TREK-2-positive cells (left) and the mean optical density of TREK-2-positive cells (right) in layer II of the EC. (C) Western blot showed that siRNA-treatment significantly decreased the level of TREK-2 channel proteins in the EC (**p < 0.001). A band that had a molecular mass of $60 kDa corresponding to the reported molecular mass of TREK-2 channels (Kang et al., 2007b; Simkin et al., 2008) was detected in the lysates of the EC. (D) Baclofen-induced increases in outward HCs were significantly reduced in slices cut from rats treated with siRNA. (E) siRNA treatment significantly reduced the increases in outward HCs induced by intracellular acidification (262.1 ± 28.4 pA, n = 10 slices from 3 Scr-siRNA treated rats versus 101.8 ± 11.5 pA, n = 12 slices from 4 siRNA treated rats), heat (111.1 ± 13.2 pA, n = 10 slices from 3 Scr-siRNA treated rats versus 37.5 ± 7.4 pA, n = 11 slices from 3 siRNA treated rats), and AA (in the presence of NMDG and 0 Ca 2+ ; 59.9 ± 10.6 pA, n = 10 slices from 3 Scr-siRNA treated rats versus 16.5 ± 3.0 pA, n = 12 slices from 4 siRNA treated rats) (**p < 0.001). (F) siRNA treatment conspicuously reduced the extent of outward rectification of the voltagecurrent relationship of the stellate neurons. Currents at different voltages from each cell were normalized to the absolute value of the current at À140 mV to minimize the influence of current sizes on voltage-current relationship. Each trace shows the averaged voltage-current relationship from ten cells from three rats treated with siRNA or Scr-siRNA. (G) Summarized mean latencies. Note that siRNA knockdown of TREK-2 channels blocked baclofen-induced impairment of spatial learning (**p < 0.01 versus the corresponding values in control group). (H) Representative swimming traces from the last trial of day 2 for each group. (I) Probe trial performance of each group as presented by the proportion of total time spent in each quadrant. The siRNA-treated rats showed a preference for the target quadrant and intra-EC injection of baclofen into these rats did not prevent the preference of the rats (**p < 0.01 versus 25% chance level). Data represent means ± SEM. p = 0.75 versus 25% chance level, Figure 7I ). Again, siRNA treatment failed to change the swimming speed of rats ( Figure S5D ).
Together, these results demonstrate that GABA B R activation impairs spatial learning via activation of TREK-2 channels in the EC.
DISCUSSION
Our results demonstrate that GABA B R activation drastically inhibits neuronal excitability in the EC. GABA B R-induced inhibition is mediated by TREK-2, a type of K 2P channels and requires the functions of Ga i proteins and AC-cAMP-PKA pathway. We further demonstrate that PKA and TREK-2 channels are essential for GABA B R-mediated inhibition of spatial learning assessed by Morris water maze. As schematically illustrated in Figure 8 , our results support an action mode in which GABA B R activation depresses AC-cAMP-PKA pathway and disinhibits the tonic inhibition of PKA on TREK-2 channels resulting in depression of neuronal excitability in the EC and spatial learning.
Ionic Mechanisms Underlying GABA B R-Mediated Inhibition of Neuronal Excitability and Spatial Learning
Resting K + channels are the major determinants of neuronal membrane potential and their modulation is one of the principal mechanisms by which neurotransmitters regulate neuronal excitability. The following lines of evidence clearly demonstrate that GABA B R activation generates membrane hyperpolarization by activating a resting K + conductance. First, replacement of intracellular K + with Cs + failed to induce hyperpolarization but instead a slight depolarization. Second, the net current generated by GABA B R activation had a reversal potential close to the K + reversal potential. Third, elevation of extracellular K + concentration significantly reduced baclofen-induced hyperpolarization. We have also shown that the K + channels activated by GABA B Rs are insensitive to the classic K + channel blockers, but sensitive to Ba 2+ . Whereas Ba 2+ blocks the inward rectifier K + channels which are involved in controlling RMPs and GABA B R activation has been shown to activate the inward rectifier K + channels in other neurons (Misgeld et al., 1995) , the inward rectifier K + channels are unlikely to be the targets for GABA B Rs in the EC based on the following two lines of evidence. First, the inward rectifier K + channels are sensitive to TEA and Cs + whereas application of these classic K + channel blockers failed to significantly change baclofen-induced increases in outward currents. Second, application of tertiapin, a selective inward rectifier K + channel inhibitor, did not alter the effects of baclofen. Together, all our results indicate the involvement of K 2P channels in GABA B R-mediated hyperpolarization in the EC. To identify the involved types of K 2P channels, we took the advantage of the findings that the Ba 2+ -sensitivity to different K 2P channels has been well-characterized. Among all the K 2P channels, TASK-1 (Han et al., 2002) , TASK-3 (Han et al., 2002; Kim et al., 2000) , TREK-1 , TREK-2 (Han et al., 2002) , TWIK-1 , and TRESK (Kang et al., 2004; Sano et al., 2003) are sensitive to Ba 2+ . We therefore examined the roles of these K 2P channels in baclofen-induced hyperpolarization. Our immunocytochemical results showed that TREK-2 channels are expressed in the EC and intracellular application of TREK-2 ABs significantly reduced baclofeninduced increases in outward HCs, indicating that GABA B R activation inhibits neuronal excitability by activating TREK-2 channels. Further evidence to support the requirement of TREK-2 channels is that application of baclofen to HEK293 cells coexpressing GABA B Rs and TREK-2 channels induces hyperpolarization whereas intracellular application of TREK-2 ABs to these cells significantly reduced the effects of baclofen.
Signaling Mechanisms whereby GABA B R Activation Inhibits Neuronal Excitability in the EC K 2P channels are modulated by a variety of G protein-coupled receptors (Chemin et al., 2003; Chen et al., 2006; Deng et al., 2006; Honoré , 2007; Kim, 2005; Lesage et al., 2000; Mathie and Veale, 2007; Talley et al., 2000) . The a subunits of G proteins are responsible for the modulation of K 2P channels (Chen et al., 2006; Deng et al., 2006; Lesage et al., 2000) . However, Ga subunits modulate K 2P channels in distinct ways; stimulation of the G s -or G q -coupled receptors inhibits (Chemin et al., 2003; Chen et al., 2006; Deng et al., 2006; Lesage et al., 2000) whereas activation of G i -coupled receptors (Lesage et al., 2000) activates K 2P channels. G q -mediated inhibition of K 2P channels is mediated via either intracellular signaling molecules (Chemin et al., 2003; Kang et al., 2006; Mathie, 2007; Veale et al., 2007) or direct G protein coupling (Chen et al., 2006; Deng et al., 2006) depending on the channel type whereas G i -induced activation requires intracellular signals because it has been reported that G i does not directly interact with K 2P channels (Chen et al., 2006) . Our results are consistent with this mechanistic framework because we have shown that GABA B R-mediated increases in outward HCs were blocked by intracellular application of GDP-b-S or in slices pretreated with PTX, suggesting the involvement of G i . Red arrows and minus mark indicate inhibition whereas green arrows and plus marks denote facilitation. GABA B R agonists activate GABA B Rs resulting in activation of the inhibitory G proteins (Gi/o). Activation of Gi/o inhibits the activity of AC leading to a reduction in the production of cAMP from ATP and an inhibition of PKA activity. Normally, PKA exerts a tonic inhibition on TREK-2 channels by phosphorylating serine 359 on TREK-2 channels. The effects of PKA require the function of AKAPs which tether PKA to TREK-2 channels. GABA B R-mediated inhibition of PKA annuls PKA-mediated tonic inhibition of TREK-2 channels resulting in an increase in the function of TREK-2 channels. The ultimate result is the inhibition of neuronal excitability in the EC and depression of spatial learning.
PKA is an important intracellular messenger downstream of G i proteins (Couve et al., 2000) . Our results indicate that PKA is necessary for GABA B R-induced increases in outward HCs. Consistent with our results, both TREK-1 Murbartiá n et al., 2005) and TREK-2 (Lesage et al., 2000) channels contain the phosphorylation site for PKA. Serine 333 in TREK-1 (Murbartiá n et al., 2005) and Serine 359 in TREK-2 are the putative PKA phosphorylation sites and activation of PKA downregulates the channel activities. We further showed that mutation of serine 359 to alanine in TREK-2 channels annulled baclofen-mediated hyperpolarization, suggesting that the effects of GABA B Rs are dependent on PKA-mediated phosphorylation of TREK-2 channels. These results could also explain the data that TASK-1 channels for which high immunoreactivity was detected in the EC ( Figures 4A and S1A) are not involved in GABA B R-mediated hyperpolarization because TASK channels do not contain PKA phosphorylation sites and are not modulated by PKA (Mathie, 2007) . AKAPs are the proteins that tether PKA to other intracellular signaling substrates (Beene and Scott, 2007; Hundsrucker and Klussmann, 2008) and both TREK-1 and TREK-2 channels interact with AKAP150 (Sandoz et al., 2008; Sandoz et al., 2006) . We therefore tested the roles of AKAPs by application of the AKAP inhibitory peptide that selectively blocks the conserved binding domain of different forms of AKAPs to PKA (Beene and Scott, 2007; Hundsrucker and Klussmann, 2008 ). Our results demonstrate that infusion of the AKAP inhibitory peptide via the recording pipettes remarkably reduced baclofen-induced hyperpolarization whereas application of the control peptide was without effect. Together, our results support a scenario in which GABA B R-mediated activation of Ga i leads to a downregulation of PKA activity resulting in a reduction in the tonic inhibition of TREK-2 channels mediated by PKA. The ultimate result is an upregulation of TREK-2 channel activity leading to hyperpolarization of entorhinal cortical neurons and depression of spatial learning (Figure 8 ).
Roles of GABA B Rs in Spatial Learning GABA B Rs have been implicated in spatial learning (Helm et al., 2005; McNamara and Skelton, 1996) . However, the mechanisms by which GABA B Rs affect spatial learning have not been determined. The EC is one of the structures essential for the consolidation and recall of memories (Haist et al., 2001; Squire et al., 2004; Steffenach et al., 2005) . The findings that a high density of GABA B Rs is expressed in the EC (Mizukami et al., 2002) and that activation of GABA B Rs remarkably depresses neuronal excitability in the EC suggest that activation of GABA B Rs controls learning and memory. Our results using Rp-cAMPS to mimic the effects of baclofen on spatial learning suggest that GABA B R-induced impairment of spatial learning is mediated by downregulation of PKA activity. The target of PKA is likely to be TREK-2 channels because downregulation of TREK-2 channels by siRNA prevents GABA B R-mediated impairment of spatial learning. Consistent with our results, TREK-2 channels are involved in the modulation of memory (Huang and Yu, 2008) . In conclusion, our study provides a novel cellular and molecular mechanism to explain the roles of GABA B Rs in learning and memory.
EXPERIMENTAL PROCEDURES Slice Preparation
Entorhinal slices were cut from rat brains as described previously (Deng et al., 2007) . Detailed methods are provided in Supplemental Data.
Whole-Cell Recordings from Stellate Neurons in Layer II of the EC Whole-cell patch-clamp recordings using an Axopatch 200B or two Multiclamp 700B amplifiers (Molecular Devices, Sunnyvale, CA) in current-or voltage-clamp mode were made from stellate neurons in layer II of the EC visually identified with infrared video microscopy (Olympus BX51WI) and differential interference contrast optics as described previously (Deng et al., 2007) . Unless stated otherwise, all the recordings were conducted at room temperature ($23 C). The recording electrodes were filled with (in mM) 130 K + -gluconate, 0.5 EGTA, 2 MgCl 2 , 5 NaCl, 2 ATP 2 Na, 0.4 GTPNa, and 10 HEPES (pH 7.4). The extracellular solution comprised (in mM) 130 NaCl, 24 NaHCO 3 , 3.5 KCl, 1.25 NaH 2 PO 4 , 2.5 CaCl 2 , 1.5 MgCl 2 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 (pH 7.4). Data were filtered at 2 kHz, digitized at 10 kHz, acquired on-line and analyzed after-line using pCLAMP 9 software (Molecular Devices).
AP firing was induced by injecting a positive current to bring the RMP to $À50 mV. Baclofen was applied after the AP firing had been stable for 5-10 min. Frequency of APs was calculated by Mini Analysis 6.0.1 (Synaptosoft Inc., Decatur, GA). HCs at À60 mV were recorded in the extracellular solution containing TTX (0.5 mM) and then averaged per minute. We subtracted the average of the HCs recorded for the last minute prior to the application of baclofen from those recorded at different time points to zero the basal level of HCs for better comparison unless stated otherwise. Voltage-current curves were constructed by using a ramp protocol from À140 mV to 0 mV at a speed of 0.1 mV/ms in the external solution supplemented with (in mM) 0.5 TTX, 100 CdCl 2 , 10 DNQX, 100 dl-APV, and 10 bicuculline. We compared the voltagecurrent curves recorded before and during the application of baclofen for $5 min.
Transfection and Electrophysiological Recordings from Transfected Cells
Detailed procedures for transfection of HEK293 cells and electrophysiological recordings from the transfected cells were described previously (Deng et al., 2007) . HEK293 cells were transfected with GABA B Rs alone, or together with TREK-2 channels or with TASK-1, TASK-3, TWIK-1, TREK-1, or TREK-2 channels alone as specified. Green fluorescent protein (GFP) was cotransfected for each experiment to identify the transfected cells. Details of the cDNA constructs are provided in Supplemental Data.
Immunocytochemistry
The methods for immunocytochemistry were described previously (Deng and Lei, 2008) . Briefly, horizontal sections (20 mm) from rat brain were washed in 0.1 M PBS and then treated with 0.3% hydrogen peroxide (H 2 O 2 ) for 10 min to quench endogenous peroxidase activity. After being rinsed in 0.1 M PBS containing 1% Triton X-100 and 5% normal donkey serum for 30 min, sections were incubated with the primary goat ABs to TASK-1, TASK-3, TWIK-1, TREK-1, or TREK-2 (Santa Cruz Biotechnology Inc.) at a dilution of 1:200 at 4 C for 12 hr. Sections were incubated at room temperature initially with biotinylated donkey anti-goat IgG (Immunocruz Staining System, Santa Cruz Biotechnology Inc.) for 1 hr, and then with HRP-streptavidin complex (Immunocruz Staining System) for 1 hr. After each incubation, sections were washed three times for a total of 30 min. Diaminobenzidine (Immunocruz Staining System) was used for a color reaction to detect the positive signals. We strictly controlled the incubation time to obtain comparable results. Finally, sections were mounted on slides, dehydrated through an alcohol range, cleared in xylene and covered with coverslips. We stained $15 nonadjacent sections for each rat and each staining was repeated by using six rats. For the siRNA experiments, we stained sections from two Scr-siRNA-treated (control) rats and two siRNA-treated rats each time and repeated three times. The images were analyzed with Image-Pro Plus 6.0 (Media Cybernetics, Inc., Bethesda, MD). Briefly, we set the range of optical densities and area (size of cells) to define the countable positive cells. Only neurons with optical densities five times more than background were considered positive. For the cell size, we set the range (area) from 70 to 130 mm 2 according to the size of stellate cells in our setting. Under this condition, the software counted the cell number automatically. Each detected cell was then inspected visually to exclude obvious artifacts.
Water Maze Task
All surgical procedures were performed under aseptic conditions. After being anesthetized with pentobarbital sodium (40 mg/kg), male Sprague-Dawley rats (150-200 g) were placed on a stereotaxic frame and implanted bilaterally with stainless steel guide cannulae (23 gauge, Plastics One, Roanoke, VA) in the entorhinal cortices. The cannulae were cemented into place with dental acrylic. The coordinates for the implantation were based on the brain atlas of Paxinos and Watson (Paxinos and Watson, 1986 ) and our preliminary experiments; anteroposterior (AP) À6.5 mm, mediolateral (ML) ± 4.5 mm and dorsoventral (DV) À5.6 mm. Cannulation sites were confirmed at the end of each experiment by slicing rat brain, Nissl staining with cresyl violet (0.1%) and viewing under a microscope ( Figure 6D ). Data from the rats with incorrect injection sites were excluded from analysis. We also infused siRNA to knock down TREK-2 channels in the EC by using osmotic pumps. Detailed procedures for this experiment are provided in Supplemental Data. Morris water maze test was conducted after 1 week of postsurgical recovery. For the hidden-platform test, rats were trained to locate a hidden platform (10 cm in diameter, submerged 1 cm) in a water maze (1.2 m in diameter) as described previously (Xu et al., 2004) . The water maze was filled with opaque water at a temperature of 20 C ± 0.5 C. Video tracking was performed using a computerized water maze system (2020 Plus Tracking System), allowing measurement of a number of parameters, including latency to find the platform, swimming distance, swimming speed, thigmotaxic behavior and quadrant analyses. Rats received 2 days of acquisition trials, each day comprising six consecutive trials, during which the platform was in a fixed position of a quadrant. On each trial, the rat was gently put in the water maze facing the wall with semirandomized starting positions, released and allowed to search for the platform for 90 s. If the rat failed to find the platform within this time, it was guided to the platform by the experimenter. The rat was allowed to stay on the platform for 30 s before next trial. The intertrial time was approximately 45 s. After completion of all six trials, the rats were dried off with towels. A probe trial with the platform unavailable for 90 s was conducted on day 3. The rats were released from the pool side opposite to the target (platform) quadrant. Time spent in the target quadrant was compared with time spent in other quadrants. The chance level spent in each quadrant is 25%. Rats received drug infusion 15 min prior to the acquisition trials on days 1 and 2 but no drug treatment on day 3 (probe trial) unless stated otherwise. All animals received 1 ml of one or two specific drugs via the 27 gauge internal cannulae that protruded approximately 0.5 mm from the guide cannulae. Infusions (0.5 ml/min) were made with a microinfusion pump (WPI, SP230IW). For the visible-platform test, the escape platform was protruded to 1.5 cm above water surface and the edge of the platform above water surface was covered with a black water-proof tape. The visible platform was placed in distinct positions for each trial of the six trials of each day for 2 days. The animal was placed into the tank facing the wall at a start point opposite to the platform from trial to trail. The same amount of saline, baclofen and Rp-cAMPS was microinjected each day before the visible-platform test.
Western Blot
Tissues for western blot were taken from three Scr-siRNA-and three siRNAtreated rats. For details, please see Supplemental Data. 
Data Analysis
